Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Pain, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome, Drug-Related Side Effects and Adverse Reactions

NCT00085163 2015-10-20

Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00230399 2015-04-21

Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer

Phase 2 Completed

15 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00043043 2013-06-19

Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00258232 2013-04-08

Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00336960 2013-03-05

Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

Phase 2 Completed

24 enrolled

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT00608595 2013-03-05

Celecoxib in Treating Patients With Early-Stage Rectal Cancer

Phase NA Terminated

10 enrolled

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT00084721 2013-01-31

Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer

Phase 1 Completed

2 enrolled

Gastrointestinal

Colonic Neoplasms, Diarrhea, Rectal Neoplasms, Colorectal Neoplasms

NCT00087256 2013-01-07

Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer

Phase 3 Terminated

18 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00466505 2012-12-19

Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery

Phase 2 Completed

17 enrolled 15 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00064181 2012-09-24

Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Completed

86 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00473980 2012-04-02

Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients

Phase 4 Completed

28 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00188565 2010-08-13

Celebrex With Preoperative Chemoradiation - Rectal Cancer

Phase 1/2 Completed

39 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00072553 2009-02-09

Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00037180 2008-09-29

For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

Phase 2 Terminated

212 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00001693 2008-03-04

Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers

Phase 1 Completed

20 enrolled

Gastrointestinal

Colorectal Neoplasms

Clinical Trials

PICC-3

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

PICC

Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer

Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC)

DETECT

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers

HFS

Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver

Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis

LDMchemoCRC

Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis

Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer

A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer

Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer

UAB0040

Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon

Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer

Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia

Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

Celecoxib in Treating Patients With Early-Stage Rectal Cancer

Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer

Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer

Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery

Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer

Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients

Celebrex With Preoperative Chemoradiation - Rectal Cancer

Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers